EMA Takes Risk-Management Approach to Initial Human Trials in Revised Guidelines

Drug Industry Daily
A A
The EMA is revising nearly decade-old guidelines on first-in-human trials after a patient died in a French study earlier this year to offer drugmakers guidance on risk management.

To View This Article:

Login

Subscribe To Drug Industry Daily